|
Form Serial Number: |
DA20230222E00032
|
1.
Date of relevant event: |
20/02/2023 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
02179 |
4.
Name of listed corporation: |
Jiangsu Recbio Technology Co., Ltd. - B - H Shares |
5.
Class of shares: |
Domestic Shares |
6.
Number of issued shares in class: |
154,824,311 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
LIU |
(Other names) |
YONG |
|
|
|
10.
Name of director (Chinese): |
刘勇 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1113 | The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
24,235,359 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 96,941,440 | 25.69 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 72,706,081 | 46.96 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2201 | Interest of corporation controlled by you |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Taizhou Yuangong Technology Partnership (Limited Partnership) (泰州元工科技合夥企業(有限合夥)) | Room A215, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陆家路西側、濱河路北側疫苗工程中心A215室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
Taizhou Baibei Biology Technology Partnership (Limited Partnership) (泰州百倍生物科技合夥企業(有限合夥)) | Room A213, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A213室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
Taizhou Guquan Biology Technology Partnership (Limited Partnership) (泰州古泉生物科技合夥企業(有限合夥)) | Room A214, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A214室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
Lianyungang Ruibaitai Medical Technology Partnership (Limited Partnership) (連雲港瑞百泰醫藥科技合夥企業(有限合夥)) | 088 Longjizhen Street, Guanyun Country, Lianyuguang City, the People's Republic of China (中國連雲港市灌雲縣龍苴鎮中大街088號) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Jiangsu Recbio Technology Co., Ltd. (the "Company") completed the conversion of its 222,498,569 unlisted domestic shares into its H shares (the "Conversion"), and the 24,235,359 unlisted domestic shares held by Mr. LIU Yong (including the corporations in column 30) were converted to H shares. The percentage level of interests in the domestic shares has increased due to the change in the number of the total issued domestic shares under the Conversion.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
22/02/2023 (dd/mm/yyyy)
|
|